
Rose McNulty
Associate Editorial Director at MJH Life Sciences
Managing Editor at American Journal of Managed Care
✏️Muscle & Fitness, M&F Hers, Men's Fitness Instagram: @rose_mcnulty
Articles
-
6 days ago |
ajmc.com | Rose McNulty
Multidisciplinary coordination is of the utmost importance to ensure appropriate gene therapy administration, and consensus recommendations presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference aimed to provide practical guidelines to supplement existing frameworks for gene therapy treatment in Duchenne muscular dystrophy (DMD).1 Gene therapies have changed the treatment landscape for inherited neurological conditions in recent years, with FDA approvals...
-
6 days ago |
ajmc.com | Rose McNulty
A home-based video assessment tool, the Duchenne Video Assessment (DVA) 2.0, is a reliable, valid measure of ease of movement for patients with Duchenne muscular dystrophy (DMD), according to a poster presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference.1 The assessment, which utilizes a secure mobile app, may allow for the evaluation of typical performance in the home setting instead of best performance in the clinical setting, according to the study...
-
6 days ago |
patientcareonline.com | Rose McNulty
Elinzanetant significantly reduced vasomotor symptoms (VMS), also known as hot flashes, associated with menopause overall and across a range of body mass index (BMI) and smoking history subgroups, according to pooled data from the phase 3 OASIS-1 (NCT05042362) and OASIS-2 (NCT05099159) clinical trials.1,2 Researchers, led by JoAnn V Pinkerton, MD, professor of obstetrics and gynecology at the University of Virginia, Charlottesville, VA, wrote in the study abstract that understanding the...
-
1 week ago |
ajmc.com | Rose McNulty
Elinzanetant significantly reduced vasomotor symptoms (VMS), also known as hot flashes, associated with menopause overall and across a range of body mass index (BMI) and smoking history subgroups, according to pooled data from the phase 3 OASIS-1 (NCT05042362) and OASIS-2 (NCT05099159) trials.1,2 The findings were presented at the 2025 Academy of Managed Care Pharmacy Annual Meeting.
-
1 week ago |
ajmc.com | Rose McNulty
Individual social risk screening may provide distinct information about health care use compared with neighborhood-level social risk among Medicaid enrollees, a cross-sectional study published in JAMA Network Open found.1 While hospital and emergency department (ED) use was similar, the use of outpatient services differed.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 274
- Tweets
- 3K
- DMs Open
- No